ESC 365 - Does the use of anticoagulation or antiplatelet therapy increase cerebrovascular events in patients with infective endocarditis

Back

ESC Professional Premium Access

Does the use of anticoagulation or antiplatelet therapy increase cerebrovascular events in patients with infective endocarditis - a systematic review and meta-analysis

Session: Managing infective endocarditis: guidelines and beyond

Topic: Pharmacotherapy

Speaker: Associate Professor M. Diab (Rotenburg An Der Fulda, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Associate Professor Mahmoud Diab

Heart Centre of Rotenburg An Der Fulda, Rotenburg An Der Fulda (Germany)

0 follower

4 more presentations in this session

Association of anticoagulation with outcomes in patients with infective endocarditis

Speaker: Doctor S. Sheng (Stony Brook, US)

Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: a population based cohort study

Speaker: Mr T. Lee (Hong Kong, HK)

Prevalence, profile, causes and prognostic factors of surgical rejection in patients with left-sided infective endocarditis

Speaker: Doctor M. De Miguel (Valladolid, ES)

One-year outcome of elderly patients with endocarditis: a retrospective observational study

Speaker: Doctor F. Marchini (Ferrara, IT)

Access the full session

Managing infective endocarditis: guidelines and beyond

Speakers: Associate Professor M. Diab, Doctor S. Sheng, Mr T. Lee, Doctor M. De Miguel, Doctor F. Marchini

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources